Keros Therapeutics

Keros Therapeutics

Biotechnology, 1050 Waltham St, Lexington, Massachusetts, 02421, United States, 51-200 Employees

kerostx.com

  • facebook
  • LinkedIn

phone no Phone Number: 61********

Who is KEROS THERAPEUTICS

Keros is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering from rare hematologic and muscul...

Read More

map
  • 1050 Waltham St, Lexington, Massachusetts, 02421, United States Headquarters: 1050 Waltham St, Lexington, Massachusetts, 02421, United States
  • 2016 Date Founded: 2016
  • 51-200 Employees: 51-200
  • dollar-icon Revenue: $25 Million to $50 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 2834

checked-icon Does something look wrong? Fix it. | View contact records from KEROS THERAPEUTICS

Keros Therapeutics Org Chart and Mapping

Employees

Katie Dawson

Executive Medical Director

Raju Nivarthi

Associate Director of Qc

Michael Pace

Senior Clinical Project Manager

Alexandra Castiglie

Upstream Process Development Co-Op

Ruel Garcia

Director, Quality Systems and Compliance

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Keros Therapeutics

Answer: Keros Therapeutics's headquarters are located at 1050 Waltham St, Lexington, Massachusetts, 02421, United States

Answer: Keros Therapeutics's phone number is 61********

Answer: Keros Therapeutics's official website is https://kerostx.com

Answer: Keros Therapeutics's revenue is $25 Million to $50 Million

Answer: Keros Therapeutics's SIC: 2834

Answer: Keros Therapeutics has 51-200 employees

Answer: Keros Therapeutics is in Biotechnology

Answer: Keros Therapeutics contact info: Phone number: 61******** Website: https://kerostx.com

Answer: Keros is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering from rare hematologic and musculoskeletal disorders with high unmet medical need.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access